ACP issues new colorectal screening guidance
New guidelines call for screening at age 50 years in average-risk adults and age 40 years or 10 years younger than age of diagnosis in the youngest affected relative in high-risk adults.
Diagnostic Testing
No need for annual Pap test, says USPSTF
Women aged 21 to 65 years should have a Pap smear every 3 years, but those aged 30 to 65 years can wait 5 years if they also have an HPV test.
PET/CT changes brain tumor treatment plans
Physicians have changed management recommendations for almost half of patients with known or suspected brain tumors after PET/CT findings.
Childhood leukemia gets “theranostic” treatment
A new treatment platform combines a selective diagnostic test with targeted therapy for youths with acute lymphoblastic leukemia.
Leukemia: Understanding its types and treatments
This review describes the four major groups of leukemia, plus diagnostic tests and treatment regimens for each group.
Genetic predictors of AML outcome get more specific
Advanced profiling of gene mutations in acute myeloid leukemia could potentially be used to help predict prognosis and guide treatment decisions.
Antiangiogenics could be effective against new ovarian cancer subtype
A newly identified subtype of ovarian cancer that builds its own blood vessels may be vulnerable to agents that block blood vessel formation.
Surgery, chemotherapy for breast cancer usually okay in pregnancy
The majority of pregnant women with breast cancer can undergo surgery, chemotherapy, or both, but radiation therapy is generally not advised.
HPV self-testing again shows potential screening value
Another study has shown that human papillomavirus (HPV) testing of self-collected cervicovaginal specimens may be an effective way to screen more women for cervical cancer.
Inherited high-risk mutation for prostate cancer identified
Researchers have discovered a rare but recurrent mutation that increases the risk of hereditary prostate cancer by up to 20 times.
- Loading...
Loading...
Loading... 
Loading...